- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 25.03. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 14.03. | Inspira Technologies details strategic progress in respiratory care | 1 | Investing.com | ||
| 14.03. | Inspira Technologies informiert über strategische Fortschritte in der Atemwegsversorgung | 1 | Investing.com Deutsch | ||
| 13.03. | Inspira Technologies droht Delisting von der NASDAQ wegen Aktienkurs | 2 | Investing.com Deutsch | ||
| 13.03. | Inspira Technologies receives Nasdaq notification regarding minimum bid requirement | 3 | Seeking Alpha | ||
| 11.03. | Inspira Technologies Oxy B.H.N. reports FY results | 1 | Seeking Alpha | ||
| INSPIRA TECHNOLOGIES OXY BHN Aktie jetzt für 0€ handeln | |||||
| 11.03. | Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates | 83 | PR Newswire | Significant progress in HYLA blood sensor and INSPIRA ART core technologies
RA'ANANA, Israel, March 11, 2025 /PRNewswire/ -- Inspira Technologies OXY B.H.N.... ► Artikel lesen | |
| 11.03. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 10.03. | Inspira Technologies OXY B.H.N. Ltd - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
| 05.03. | Inspira Technologies OXY B.H.N. Ltd - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 04.03. | Inspira Technologies Announces Positive Results from Clinical Study of HYLA Blood Sensor, Achieving 96% Accuracy | 88 | PR Newswire | Inspira's AI-powered continuous blood monitoring technology demonstrated a high degree of accuracy in a key parameter, targeting multiple multi-billion-dollar market... ► Artikel lesen | |
| 04.03. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 11.02. | Inspira Technologies: Inspira Achieves Positive Results of Above 95% For Preventing Bloodstream Infections | 90 | PR Newswire | The ex-vivo testing demonstrated significant bacterial reduction for the innovative IV dressing technology aimed at preventing bloodstream infections in critical... ► Artikel lesen | |
| 05.02. | EXCLUSIVE: Isreal-Based Inspira Technologies Integrates New Oxygenation Indicator Into HYLA Blood Sensor To Enhance Critical Care Monitoring | 1 | Benzinga.com | ||
| 05.02. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 27.01. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 17.01. | Inspira Technologies collaborates with Zriha Medical to launch production line | 7 | Seeking Alpha | ||
| 14.01. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 14.01. | Inspira Technologies Unveils Modular Configuration for Revolutionary VORTX Blood Oxygenation Delivery Technology | 98 | PR Newswire | The technology has the potential to provide life-saving support for the approximately 20 million ICU patients with respiratory failure annually
RA'ANANA, Israel... ► Artikel lesen | |
| 14.01. | EXCLUSIVE: Inspira Technologies Unveils Modular Configuration For VORTX Blood Oxygenation Delivery Technology | 2 | Benzinga.com |
Seite:
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,112 | -7,30 % | Sernova Biotherapeutics Inc: Sernova to continue to Cohort C T1D trial in H2 2025 | ||
| ATOSSA THERAPEUTICS | 0,590 | +0,68 % | Atossa-Therapeutics-Direktor Remmel H. Lawrence kauft Aktien für 7.000 US-Dollar | ||
| PING AN HEALTHCARE | 0,792 | -4,67 % | Ping An Healthcare and Technology Company Limited: Ping An Health Reports First Full-Year Profit in 2024 | Synergies Between Health Care and Insurance Drive Scalable GrowthAI Innovations Fuel Continued Success
SHANGHAI and HONG KONG, March 13, 2025 /PRNewswire/ -- Ping An Healthcare and Technology... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,014 | -20,00 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,302 | +2,03 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| CYTOSORBENTS | 0,880 | -2,98 % | Cytosorbents Corp: CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights | 2024 marked by strong commercial execution and improved operating leverage
Company continues to expect DrugSorb-ATR regulatory decisions from Health Canada and... ► Artikel lesen | |
| VERU | 0,516 | -2,18 % | Veru Aktie: Kreuzung ohne klare Richtung! | Die Veru-Aktie konnte im jüngsten Handel einen leichten Aufschwung verzeichnen. Am 22. März stieg der Kurs um 2,35% auf 0,48 EUR, was eine positive Entwicklung gegenüber dem Vortagsschluss darstellt.... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,639 | -1,92 % | H.C. Wainwright cuts Tempest Therapeutics stock target to $16 | ||
| VOLITIONRX | 0,560 | 0,00 % | VolitionRx Limited Announces Full Fiscal Year 2024 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Monday, March 31 at 4:30 p.m. U.S. Eastern Time HENDERSON, Nevada, March 31, 2025 /PRNewswire/ -- VolitionRx... ► Artikel lesen | |
| EKSO BIONICS | 0,343 | -13,82 % | Ekso Bionics Holdings Aktie: Beeindruckende Innovationskraft | Der Exoskelett-Hersteller verzeichnet im letzten Quartal 2024 Umsatzsteigerungen und Margenwachstum, kämpft jedoch mit Jahresrückgang bei hoher Aktienvolatilität. Ekso Bionics meldete für das vierte... ► Artikel lesen | |
| IMUNON | 0,900 | -2,17 % | Imunon, Inc.: IMUNON Finalizes Phase 3 Study Design with FDA for IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer | First and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in patients with advanced ovarian cancer Initiation of trial sites underway for ground-breaking Phase 3... ► Artikel lesen | |
| BEYOND AIR | 0,238 | +6,25 % | Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site | ||
| AVINGER | 0,340 | -6,08 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
| NOVACYT | 0,480 | -2,54 % | Novacyt S.A. - Liquidity Agreement and Total Voting Rights | ||
| AROVELLA THERAPEUTICS | 0,039 | -2,53 % | AROVELLA THERAPEUTICS LIMITED: Cancel - Proposed issue of securities - ALA |
INSPIRA TECHNOLOGIES OXY BHN LTD gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,634 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INSPIRA TECHNOLOGIES OXY BHN LTD finden Sie auf Wallstreet Online.
